Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03094325 · ClinicalTrials.gov registry record · NA

On-pump Intraoperative Echocardiography

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03094325: Completed NA study, sponsored by NYU Langone Health.

NCT03094325 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03094325, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This pilot study uses an ultrasound probe that is currently clinically used to assess pituitary anatomy, the Hitachi-Aloka high resolution pituitary transducer to measure left ventricular (LV) septal thickness during cardiopulmonary bypass in the performance of surgical septal myectomy. Septal thickness will be assessed and can be visualized during the procedure and if it is likely to improve the efficacy and safety of the procedure. The probe has FDA clearance for a variety of intra-operative surgical procedures but will be off-label for this cardiac surgical protocol.

Primary Outcome

Center tendency parameters(mean, standard deviation)

Interventions

  • DEVICE Pre Operative On-pump intraoperative echocardiography
  • DEVICE Pre Operative Transesophageal echocardiography (TEE) imaging
  • DEVICE Post Operative On-pump intraoperative echocardiography
  • DEVICE Post Operative Transesophageal echocardiography (TEE) imaging

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-03-23
Est. Completion 2018-11-23
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT03094325 record still lists

NCT03094325 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 4 interventions - of which Pre Operative On-pump intraoperative echocardiography is the first listed.

NCT03094325 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03094325 about?

NCT03094325 is a clinical study titled "On-pump Intraoperative Echocardiography". This pilot study uses an ultrasound probe that is currently clinically used to assess pituitary anatomy, the Hitachi-Aloka high resolution pituitary transducer to measure left ventricular (LV) septal thickness during cardiopulmonary bypass in the performance of surgical septal myectomy. Septal thick...

What is the current status of trial NCT03094325?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-03-23. Estimated completion is 2018-11-23.

What interventions are being tested in trial NCT03094325?

The interventions under investigation include: Pre Operative On-pump intraoperative echocardiography (DEVICE), Pre Operative Transesophageal echocardiography (TEE) imaging (DEVICE), Post Operative On-pump intraoperative echocardiography (DEVICE), Post Operative Transesophageal echocardiography (TEE) imaging (DEVICE).

Who is sponsoring clinical trial NCT03094325?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03094325's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03094325, the US trial registry maintained by the National Library of Medicine. NCT03094325 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.